Pricing Log in Create free account

Rocket Pharmaceuticals, Inc. (RCKT) vs ARS Pharmaceuticals, Inc. (SPRY)

Rocket Pharmaceuticals, Inc. and ARS Pharmaceuticals, Inc. are both Biotechnology companies. Rocket Pharmaceuticals, Inc. and ARS Pharmaceuticals, Inc. are of similar size ($267.3M and $263.5M). Across the 11 metrics below, Rocket Pharmaceuticals, Inc. leads on 6 and ARS Pharmaceuticals, Inc. on 5.

Valuation

Metric RCKT SPRY Biotechnology median
P/E n/m n/m 10.60
P/S n/m 2.29 9.40
P/B 0.73 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 2.57 9.02
Earnings yield (6.69%) (71.89%) (32.88%)
Free cash flow yield (63.78%) (70.96%) (23.13%)

Profitability

Metric RCKT SPRY Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% (161.50%) 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% (149.89%) 0.00%
Return on equity (4.77%) 0.00% (51.96%)
Return on assets (4.09%) 0.00% (46.06%)
Return on invested capital (114.71%) 0.00% 0.00%

Growth

Metric RCKT SPRY Biotechnology median
Revenue growth (TTM) — (14.45%) 6.76%
EPS growth (last fiscal year) 26.37% (2,275.00%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RCKT SPRY Biotechnology median
Debt to equity 0.05 0.00 0.00
Current ratio 9.24 3.25 4.97
Net debt to EBITDA 0.77 0.42 1.01

Dividend

Metric RCKT SPRY Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric RCKT SPRY Biotechnology median
Market cap 267.30m 263.53m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack